• Roivant Sciences director Meghan FitzGerald exercised stock options for 10,000 common shares on June 30 at USD 8.8.
• FitzGerald sold 10,000 common shares the same day at USD 34.9.
• Directly held common shares totaled 42,963 following the transactions.
• Stock options beneficially owned totaled 38,578 following the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001349297-26-000004), on July 02, 2026, and is solely responsible for the information contained therein.